Description

N*1*-(3-Bromo-6-Morpholin-4'-Yl-4-(Trifluoromethyl)Pyridin-2-Yl)Ethane-1,2-Diamine is a high-purity, advanced pharmaceutical intermediate featuring a complex heterocyclic structure with bromo, morpholino, and trifluoromethyl substituents. This compound is specifically engineered for use in the synthesis of novel active pharmaceutical ingredients (APIs), where its unique scaffold provides critical structural diversity and functional handles for further derivatization. It is an essential building block for medicinal chemistry research and development, particularly targeting therapeutic areas requiring sophisticated small-molecule candidates.

Application

• Pharmaceutical Intermediate: A key precursor in the multi-step synthesis of novel drug candidates, especially in oncology and central nervous system (CNS) therapeutic research.
• Medicinal Chemistry R&D: Serves as a versatile scaffold for structure-activity relationship (SAR) studies and lead optimization in drug discovery programs.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and process development for the pharmaceutical industry.
• Proteolysis Targeting Chimera (PROTAC) Development: Used in the construction of heterobifunctional molecules designed for targeted protein degradation.
• Kinase Inhibitor Synthesis: Incorporated into molecules designed to modulate kinase activity, a prominent target class in modern therapeutics.
• Agrochemical Research: Potential application as an intermediate in the development of new crop protection agents with novel modes of action.

Basic Information

Product Name	N*1*-(3-Bromo-6-Morpholin-4'-Yl-4-(Trifluoromethyl)Pyridin-2-Yl)Ethane-1,2-Diamine
CAS No.	1089330-42-6
Molecular Formula	C12H16BrF3N4O
Molecular Weight	393.19 g/mol
Synonyms	1,2-Ethanediamine, N1-[3-bromo-6-(4-morpholinyl)-4-(trifluoromethyl)-2-pyridinyl]-; N1-(3-Bromo-6-morpholino-4-(trifluoromethyl)pyridin-2-yl)ethane-1,2-diamine; 2-[(2-Aminoethyl)amino]-3-bromo-6-morpholin-4-yl-4-(trifluoromethyl)pyridine; 1089330-42-6; 3-Bromo-6-morpholino-4-(trifluoromethyl)pyridine-2,2'-diamine derivative
EINECS	Contact for details

Quality Control

Our N*1*-(3-Bromo-6-Morpholin-4'-Yl-4-(Trifluoromethyl)Pyridin-2-Yl)Ethane-1,2-Diamine is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the high standards required for pharmaceutical R&D. Certificates of Analysis (COA) detailing batch-specific results are provided and can be tailored to meet specific client requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). The compound is light-sensitive and should be handled under appropriate conditions to maintain stability.

Specification

Item	Specification
Appearance	White to off-white solid
Identification (HPLC)	Conforms
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.